Artemis Medicare Services Sets November 2 FY27 Earnings Call

Artemis Medicare Services Limited will hold its Q2 and H1 FY27 earnings conference call at 11:00 AM IST on November 2, 2026, following a Q1 FY27 performance in which revenue rose 12.7% year-on-year to ₹287.32 crore and net profit increased 48.3% to ₹31.44 crore.

When is Artemis Medicare's Q2 and H1 FY27 earnings call?

Artemis Medicare's earnings conference call is scheduled for November 2, 2026, at 11:00 AM IST. The company issued an intimation under Regulation 30 of the Listing Obligations and Disclosure Requirements regulations on October 27 regarding the analyst and investor meet.

The call relates to the September 2026 quarter and the first half of FY27. The Q2 FY27 reporting period runs from July 1, 2026, to September 30, 2026. The company has also informed exchanges that its board will meet on October 30, 2026, to consider and approve unaudited financial results for Q2 and H1 FY27.

The scheduled call gives investors an opportunity to hear management's discussion after the board considers the financial statements. The available disclosures do not provide a verified public analyst estimate for Q2 FY27 revenue or profit, so the forthcoming results should be assessed against reported historical figures rather than assumed forecasts.

What did Artemis Medicare report in Q1 FY27?

Artemis Medicare reported consolidated revenue of ₹287.32 crore for the quarter ended June 30, 2026, up 12.7% from ₹255.00 crore in Q1 FY26. Net profit rose 48.3% year-on-year to ₹31.44 crore from ₹21.00 crore, while earnings per share increased to ₹1.98 from ₹1.35.

The company also improved sequentially from Q4 FY26. Revenue was 2.9% higher than ₹279.23 crore in the preceding quarter, while net profit was 3.8% above ₹30.28 crore. Total income for Q1 FY27 stood at ₹292.70 crore and expenditure was ₹250.07 crore.

Operating profitability strengthened during the quarter. Operating profit margin was reported at 19.64%, compared with 16.2% a year earlier and 18.5% in Q4 FY26. Net profit margin improved to 10.74% from 8.1% in Q1 FY26. The result disclosures stated that there were no exceptional items in either the current or comparable year-ago quarter, making the reported profit growth directly comparable.

What is the comparison base for Artemis Medicare's Q2 FY27 results?

Artemis Medicare will be compared with revenue of ₹275.00 crore and net profit of ₹30.00 crore reported in Q2 FY26, the quarter ended September 2025. This is the reported base for assessing year-on-year movement when the September 2026 results are released.

The comparison follows a period of improving reported profitability. In Q2 FY26, earnings per share were ₹1.90, compared with ₹1.42 in Q2 FY25, while net profit increased 35% year-on-year to ₹29.97 crore. The latest Q1 FY27 result of ₹287.32 crore in revenue and ₹31.44 crore in net profit therefore provides the most recent operating reference before the September-quarter announcement.

Indian listing rules generally require September-quarter financial results to be published within 45 days of the quarter-end, which sets November 14, 2026, as the outer deadline cited for the Q2 FY27 disclosure. Artemis Medicare's October 30 board meeting and November 2 call fall ahead of that deadline.

Why do Artemis Medicare's margins matter to investors?

Artemis Medicare's margin expansion matters because net profit grew much faster than revenue in Q1 FY27. Revenue increased 12.7%, whereas net profit rose 48.3%, alongside a 3.40 percentage point increase in operating profit margin and a 2.65 percentage point increase in net profit margin.

The Q1 result followed a broader growth phase for the hospital operator. Artemis Medicare ended FY25 with gross revenue of ₹922 crore and net profit of ₹49 crore. For the trailing 12 months ended April 2026, the supplied data places revenue at ₹913.26 crore and net profit at ₹83.46 crore.

The company operates in an Indian healthcare industry for which revenue growth is forecast at 18% annually over the next two years, according to the provided data. Artemis Medicare's revenue is forecast to grow at an average annual rate of 24% over the same period. These are forecasts rather than reported results, and the Q2 filing will provide a more current indication of whether the company continues to deliver growth and margin improvement.

Conclusion

The scheduled November 2 earnings call places attention on Artemis Medicare's Q2 and H1 FY27 financial update after a Q1 marked by higher revenue, stronger margins and a 48.3% rise in net profit. The key reported benchmark for the September quarter is Q2 FY26 revenue of ₹275 crore and net profit of ₹30 crore.

Investors will next watch the October 30 board meeting, the release of unaudited Q2 and H1 FY27 results, and management's comments during the November 2 call. The available information does not include a verified public estimate for the September-quarter revenue or profit figures.